Efficacy and Safety of 0.01% and 0.02% Atropine for the Treatment of Pediatric Myopia Progression
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Efficacy and Safety of 0.01% and 0.02% Atropine for the Treatment of Pediatric Myopia Progression Over 3 Years: A Randomized Clinical Trial
JAMA Ophthalmol 2023 Jun 01;[EPub Ahead of Print], K Zadnik, E Schulman, I Flitcroft, JS Fogt, LC Blumenfeld, TM Fong, E Lang, HD Hemmati, SP ChandlerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.